Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone
- PMID: 11181551
- DOI: 10.1210/endo.142.3.8006
Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone
Abstract
Osteoclastic bone resorption requires a number of complex steps that are under the control of local regulatory molecules. Osteopontin is expressed in osteoclasts and is also present in bone matrix; however, its biological function has not been fully understood. To elucidate the role of osteopontin in the process of osteoclastic bone resorption, we conducted ectopic bone implantation experiments using wild-type and osteopontin knockout mouse. In the wild-type group, bone discs from calvariae implanted ectopically in muscle were resorbed, and their mass was reduced by 25% within 4 weeks. In contrast, the mass of the bone discs from calvariae of osteopontin knockout mice was reduced by only 5% when implanted in osteopontin knockout mice. Histological analyses indicated that the number of osteoclasts associated with the implanted bones was reduced in the osteopontin knockout mice. As osteopontin deficiency does not suppress osteoclastogenesis per se, we further examined vascularization immunohistologically and found that the number of vessels containing CD31-positive endothelial cells around the bone discs implanted in muscle was reduced in the osteopontin knockout mice. Furthermore, sc implantation assays indicated that the length and branching points of the newly formed vasculatures associated with the bone discs were also reduced in the absence of osteopontin. In this assay, tartrate-resistant acid phosphatase-positive area of the bone discs was also reduced in the osteopontin knockout mice, indicating further the link between the osteopontin-dependent vascularization and osteoclast accumulation. The bone resorption defect could be rescued by topical administration of recombinant osteopontin to the bones implanted in muscle. These observations indicate that osteopontin is required for efficient vascularization by the hemangiogenic endothelial cells and subsequent osteoclastic resorption of bones.
Similar articles
-
Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.In Vivo. 2005 Mar-Apr;19(2):335-41. In Vivo. 2005. PMID: 15796195
-
Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin.J Biol Chem. 2001 Apr 20;276(16):13065-71. doi: 10.1074/jbc.M010938200. Epub 2001 Jan 22. J Biol Chem. 2001. PMID: 11278791
-
Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.J Periodontal Res. 1997 Aug;32(6):480-6. doi: 10.1111/j.1600-0765.1997.tb00563.x. J Periodontal Res. 1997. PMID: 9379315
-
[Molecular biology in regulation of kidney functions: Osteopontin].Nihon Rinsho. 2006 Feb;64 Suppl 2:242-5. Nihon Rinsho. 2006. PMID: 16523896 Review. Japanese. No abstract available.
-
Molecular aspects of osteoclast function.Inflamm Res. 1996 Jan;45(1):1-9. doi: 10.1007/BF02263497. Inflamm Res. 1996. PMID: 8821771 Review.
Cited by
-
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Mol Metab. 2014 Mar 22;3(4):384-93. doi: 10.1016/j.molmet.2014.03.004. eCollection 2014 Jul. Mol Metab. 2014. PMID: 24944898 Free PMC article. Review.
-
Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis.Lab Invest. 2020 Mar;100(3):400-413. doi: 10.1038/s41374-019-0326-6. Epub 2019 Sep 30. Lab Invest. 2020. PMID: 31570773 Free PMC article.
-
Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins.J Bone Miner Metab. 2008;26(5):514-9. doi: 10.1007/s00774-008-0859-z. Epub 2008 Aug 30. J Bone Miner Metab. 2008. PMID: 18758911
-
Custom design of the cardiac microenvironment with biomaterials.Circ Res. 2005 Jul 8;97(1):8-15. doi: 10.1161/01.RES.0000173376.39447.01. Circ Res. 2005. PMID: 16002755 Free PMC article. Review.
-
NMR Metabolomics Assessment of Osteogenic Differentiation of Adipose-Tissue-Derived Mesenchymal Stem Cells.J Proteome Res. 2022 Mar 4;21(3):654-670. doi: 10.1021/acs.jproteome.1c00832. Epub 2022 Jan 21. J Proteome Res. 2022. PMID: 35061379 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials